Annexon (ANNX) Enterprise Value (2019 - 2026)
Annexon's (ANNX) quarterly Enterprise Value came in at -$225.0 million in Q1 2026, up 15.0% year-on-year from -$195.7 million in Q1 2025, and up 4.78% quarter-over-quarter from -$236.3 million in Q4 2025.
Annexon (ANNX) Enterprise Value (2019 - 2026) Analysis & Trends
Annexon's Enterprise Value history runs 8 years deep, the most recent figure standing at -$225.0 million for Q1 2026.
- On a quarterly basis, Enterprise Value rose 15.0% year-over-year to -$225.0 million in Q1 2026; TTM through Mar 2026 was -$225.0 million, a 15.0% increase from a year earlier, with the FY2025 full-year figure at -$236.3 million, up 24.51% from the prior year.
- Enterprise Value grew to -$225.0 million in Q1 2026 per ANNX's latest filing, from -$236.3 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$94.4 million in Q1 2022 and bottomed at -$369.7 million in Q2 2024.
- The 5-year median for Enterprise Value is -$236.3 million (2025), against an average of -$239.4 million.
- Across the five-year window, Enterprise Value soared 71.1% in 2022 and slumped 142.76% in 2023, its largest moves.
- Year by year, Enterprise Value stood at -$243.7 million in 2022, then fell by 7.0% to -$260.7 million in 2023, then decreased by 20.06% to -$313.0 million in 2024, then gained by 24.51% to -$236.3 million in 2025, then increased by 4.78% to -$225.0 million in 2026.
- Per Business Quant, the three latest ANNX Enterprise Value figures stand at -$225.0 million (Q1 2026), -$236.3 million (Q4 2025), and -$188.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | -61.40 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.83 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -4.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -1.91 Bn |
| 10 | Annexon | 1.02 Bn | 798.41 Mn | - | -225.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -225.03 Mn |
| Dec 31, 2025 | -236.33 Mn |
| Sep 30, 2025 | -188.72 Mn |
| Jun 30, 2025 | -227.02 Mn |
| Mar 31, 2025 | -264.73 Mn |
| Dec 31, 2024 | -313.05 Mn |
| Sep 30, 2024 | -341.15 Mn |
| Jun 30, 2024 | -369.73 Mn |
| Mar 31, 2024 | -265.98 Mn |
| Dec 31, 2023 | -260.75 Mn |
| Sep 30, 2023 | -166.30 Mn |
| Jun 30, 2023 | -193.97 Mn |
| Mar 31, 2023 | -229.20 Mn |
| Dec 31, 2022 | -243.69 Mn |
| Sep 30, 2022 | -270.55 Mn |
| Jun 30, 2022 | -178.63 Mn |
| Mar 31, 2022 | -94.41 Mn |
| Dec 31, 2021 | -243.88 Mn |
| Sep 30, 2021 | -271.37 Mn |
| Jun 30, 2021 | -302.39 Mn |